According to the immunohistochemistry assay, the expression of α-SMA, a well-known marker of CAFs, was consistent with FAP in the pancreatic cancer xenograft model with the co-injection of PANC-1 and CAFs, confirming the presence of abundant FAP-positive CAFs. The gene discussed is FAP; the disease is pancreatic neoplasm.